Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team.
Schooley RT, Campbell TB, Kuritzkes DR, Blaschke T, Stein DS, Rosandich ME, Phair J, Pottage JC, Messari F, Collier A, Kahn J.
Schooley RT, et al. Among authors: stein ds.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):363-70. doi: 10.1097/00042560-199608010-00006.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996.
PMID: 8673545
Clinical Trial.